Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
ES

EMILY SILVERBERG

KING & SPALDING LLP · Washington, DC
Registered · LDAActive

At a glance

Works on
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career
Washington, DC · current
Government experience
Apr 2025-May 2026 Deputy Chief of Staff/Legislative Director Jan 2021-Apr 2025 Legislative Director May 2014-Jan 2020 Senior Legislative/Policy Advisor Jan 2013-April 2018 Staff/Legislative Assistant Sep 2012-Jan 2013 Congressional Intern.
Apr 2025-May 2026 Deputy Chief of Staff/LegislativevDirector Jan 2021-Apr 2025 Legislative Director May 2014-Jan 2020 Senior Legislative/Policy Advisor Jan 2013-April 2018 Staff/Legislative Assistant Sep 2012-Jan 2013 Congressional Intern.
Apr 2025-May 2026 Deputy Chief of Staff/Legislative Director Jan 2021-Apr 2025 Legislative Director May 2014-Jan 2020 Senior Legislative/Policy Advisor Jan 2013-April2018 Staff/Legislative Assistant Sep 2012-Jan 2013 Congressional Intern.
Deputy Chief of Staff/ Legislative Director to Representative Paul Tonko
Covered official positions, as disclosed on federal filings

The past 12 months

Clients
12
past 12 months
Filings
12
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATECenters For Medicare and Medicaid Services (CMS)Health Resources & Services Administration (HRSA)

Specific issues

Advocacy related to legislation to H.R. 6799 and eliminating SSDI waiting period for individuals with young onset Alzheimers.
Health Issues · 2026 Q2
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Medicare/Medicaid · 2026 Q2
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Health Issues · 2026 Q2
Advocacy related to Bladder cancer treatment and blue light cystoscopy, H.R. 8032.
Health Issues · 2026 Q2
Advocate on Wound Care LCDs and payment rates; 361 Process.
Medicare/Medicaid · 2026 Q2
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Medicare/Medicaid · 2026 Q2

Clients

$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings12
2026 Q2
SENIOR CARE PHARMACY COALITION
Q2lda.gov →
2026 Q2
PHOTOCURE, INC.
Q2lda.gov →
2026 Q2
EGENESIS INC.
Q2lda.gov →
2026 Q2
ADVENTIST HEALTHCARE
Q2lda.gov →
2026 Q2
ACADIA HEALTHCARE
Q2lda.gov →
2026 Q2
VOICES OF ALZHEIMER'S, INC.
Q2lda.gov →
2026 Q2
MARC COALITION
Q2lda.gov →
2026 Q2
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL)
Q2lda.gov →
2026 Q2
COALITION OF INDEPENDENT DISPUTE RESOLUTION ENTITIES, INC. (CIDRE)
Q2lda.gov →
2026 Q2
EXAMWORKS
Q2lda.gov →
2026 Q2
POINTCLICKCARE TECHNOLOGIES, INC.
Q2lda.gov →
2026 Q3
MEHARRY MEDICAL COLLEGE
RRlda.gov →